Rene Lafont - Biophytis Scientific Board
| BPTS Stock | USD 7.62 0.48 5.93% |
Insider
Rene Lafont is Scientific Board of Biophytis
| Age | 78 |
| Address | Sorbonne University, Paris, France, 75005 |
| Phone | 33 1 44 27 23 00 |
| Web | https://www.biophytis.com |
Biophytis Management Efficiency
The company has return on total asset (ROA) of (0.5278) % which means that it has lost $0.5278 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.444) %, meaning that it created substantial loss on money invested by shareholders. Biophytis' management efficiency ratios could be used to measure how well Biophytis manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Biophytis' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 4.61 in 2024, whereas Return On Tangible Assets are likely to drop (1.92) in 2024. At this time, Biophytis' Total Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 884.1 K in 2024, despite the fact that Non Currrent Assets Other are likely to grow to (950.00).Management Performance
| Return On Equity | -12.44 | ||||
| Return On Asset | -0.53 |
Biophytis Leadership Team
Elected by the shareholders, the Biophytis' board of directors comprises two types of representatives: Biophytis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biophytis. The board's role is to monitor Biophytis' management team and ensure that shareholders' interests are well served. Biophytis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biophytis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edouard Bieth, Chief Officer | ||
| Philippe Rousseau, Chief Officer | ||
| Waly Dioh, Chief Officer | ||
| Pierre Dilda, Chief Officer | ||
| Benoit Canolle, Chief Officer | ||
| Stanislas Veillet, Chairman CEO | ||
| Rene Lafont, Scientific Board | ||
| Nicolas Fellmann, Chief Officer | ||
| FFPM MBA, Chief Officer | ||
| Teylan, Financial Controller |
Biophytis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biophytis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -12.44 | ||||
| Return On Asset | -0.53 | ||||
| Current Valuation | 9.73 B | ||||
| Shares Outstanding | 286.5 K | ||||
| Shares Owned By Institutions | 0.04 % | ||||
| Number Of Shares Shorted | 368.95 K | ||||
| Price To Book | 2.26 X | ||||
| EBITDA | (15.09 M) | ||||
| Net Income | (17.03 M) | ||||
| Cash And Equivalents | 23.93 M |
Pair Trading with Biophytis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biophytis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biophytis will appreciate offsetting losses from the drop in the long position's value.Moving together with Biophytis Stock
| 0.85 | DVAX | Dynavax Technologies | PairCorr |
| 0.9 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.83 | BMY | Bristol Myers Squibb | PairCorr |
| 0.8 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Biophytis Stock
| 0.82 | BSGM | Biosig Technologies | PairCorr |
| 0.69 | AMRX | Amneal Pharmaceuticals | PairCorr |
| 0.64 | DCPH | Deciphera Pharmaceuticals | PairCorr |
| 0.62 | MRK | Merck Company Earnings Call Today | PairCorr |
| 0.51 | AMGN | Amgen Inc Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Biophytis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biophytis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biophytis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biophytis to buy it.
The correlation of Biophytis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biophytis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biophytis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biophytis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biophytis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Biophytis Stock please use our How to Invest in Biophytis guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Biophytis Stock analysis
When running Biophytis' price analysis, check to measure Biophytis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biophytis is operating at the current time. Most of Biophytis' value examination focuses on studying past and present price action to predict the probability of Biophytis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biophytis' price. Additionally, you may evaluate how the addition of Biophytis to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Biophytis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biophytis. If investors know Biophytis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biophytis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (128.39) | Return On Assets (0.53) | Return On Equity (12.44) |
The market value of Biophytis is measured differently than its book value, which is the value of Biophytis that is recorded on the company's balance sheet. Investors also form their own opinion of Biophytis' value that differs from its market value or its book value, called intrinsic value, which is Biophytis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biophytis' market value can be influenced by many factors that don't directly affect Biophytis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biophytis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biophytis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biophytis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.